Obermatt
See Similar Stocks →

CapsoVision

NAQ:CV · US1409351079
Health Care Equipment & SuppliesSmall

360

49
Profit price76
Owner Earnings Yield1
Dividend Yield1
Price/Sales12
EV / Gross Profit3
Price/Book100
Return on Capital1
Cash Return on Capital8
Return on Equity3
EBIT Margin6
Gross Profitability32
Accruals89
Owner Earnings Margin10
Sales growth58
Profit growth65
Reinvestment85
Price momentum87
Debt load81
Refinancing52
Debt Payback1
Liquidity93
Analyst ratings100
Opinion Changes2
Price Target Upside42
Market mood3
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

CapsoVision clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2005
Employees96
Websitecapsovision.com
ISINUS1409351079
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
GastroenterologyHealth DiagnosticsBiomedical EngineeringOncologyHealth Care

Description

CapsoVision, Inc. operates as a commercial-stage medical technology company. The company focuses on creating diagnostic and screening products to identify abnormalities of the GI tract. It develops advanced imaging and AI technologies for creating s…

Analysis

Story stock

CapsoVision, Inc. trades at an expensive price on a weak set of business metrics, a combination we flag as a story stock.

Valuation data is not available for this company.

Growth is solid; the safety picture is sturdy. The company scores 8/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
70
2026

All-time high

70

Jun 2026

All-time low

70

Jun 2026

Average rank

70

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
12
—
—
—
Price/Earnings
—
—
—
—
Price/Book
100
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
51
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare CapsoVision with its peers
Lumexa Imaging
NSQ:LMRI
24
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
NextNav
NAQ:NN
38
CountryUSA
IndustrySoftware
SizeSmall
Full Stock Analysis →
AMC Robotics
NAQ:AMCI
1
CountryUSA
IndustryElectronic Equipment, Instruments & Components
SizeX-Small
Full Stock Analysis →
Cricut
NSQ:CRCT
71
CountryUSA
IndustryHousehold Durables
SizeMedium
Full Stock Analysis →
Caris Life Sciences
NSQ:CAI
93
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
National Presto Industries
NYQ:NPK
86
CountryUSA
IndustryAerospace & Defense
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →